HURA:NASDAQ, TuHURA Biosciences, Inc.

HURA stock overview

TuHURA Biosciences, Inc. (HURA:NASDAQ) closed at $1.25 on November 20, 2026, down 8.09% on the day. The stock trades 63.6% below its 52-week high of $3.43 and 204.9% above its 52-week low of $0.410. Over the past year, it lost 33.9%. TuHURA Biosciences, Inc. is part of the Health Care sector.

Key figures

Price
$1.25
Day change
-8.09%
Volume
523,519
Average volume
327,592
Market cap
82M+
52-week range
$0.410 – $3.43
50-day average
$1.86
200-day average
$2.03

Price action over the past year

In 252 trading sessions since November 20, 2025, HURA closed higher on 105 days (42%). Its best day was February 10, 2026 (+60.49%) and its worst was December 9, 2025 (-40.91%). The stock moved 10% or more in a single session 27 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

HURA news

About TuHURA Biosciences, Inc.

Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs. The company is developing two late-stage, Phase 3-ready therapeutics for clear unmet medical needs with reduced risk development programs. The two programs are VAL-083 for GBM and REM-001 for CMBC. VAL-083 is a small-molecule chemotherapeutic with a novel mechanism of action that has demonstrated clinical activity against a range of cancers, including the central nervous system, ovarian, and other solid tumors. The company is also advancing its proprietary late stage photodynamic therapy (PDT) platform that holds promise as a localized cutaneous or visceral tumor treatment as well as in other potential indications.

Similar stocks

Find more stocks like HURA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.